Aβ-IN-9

Aβ-IN-9

• UNSPSC Description: Aβ-IN-9 (Compound 6i) is an amyloid-beta aggregation inhibitor. Aβ-IN-9 can inhibit Aβ aggregation to form nano-rod-like structures, thereby preventing β-sheet formation. Aβ-IN-9 can be used for Alzheimer's disease research[1].
• Target Antigen: Amyloid-β
• Type: Reference compound
• Related Pathways: Neuronal Signaling
• Applications: Neuroscience-Neurodegeneration
• Field of Research: Neurological Disease
• Assay Protocol: https://www.medchemexpress.com/aβ-in-9.html
• Smiles: OC1=C(O)C=CC(CCNC(/C=C/C2=CC(O)=C(O)C=C2)=O)=C1
• Molecular Weight: 315.32
• References & Citations: [1]Xu F, et al. Synthesis and evaluation of catecholamine derivatives as amyloid-beta aggregation inhibitors. Bioorg Med Chem Lett. 2024 Jul 15;107:129788.
• Shipping Conditions: Room temperature
• Clinical Information: No Development Reported